Oragenics (OGEN) announced the appointment of Janet Huffman as CFO, effective March 7. Huffman is a financial executive with more than a dozen years of leadership experience at publicly traded and private healthcare companies. Huffman served as CFO for Trxade Health (MEDS), a Nasdaq-listed company focused on health services IT for retail pharmacies.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on OGEN: